It is hence paramount to control for placebo effects in modern brain therapies to avoid false hopes.The FDA approved external trigeminal nerve stimulation (TNS) in 2019 as the first non-drug device for treating ADHD, researchers said in background notes.The treatment involves placing electrodes on the foreheads of children with ADHD while they sleep.The battery-powered electrodes stimulate the trigeminal nerve, targeting a branch of the facial nerve thought to activate the brainstem and, from there, other brain regions linked to ADHD, researchers said.The FDAs approval came following a small U.S
They can cause dumping syndrome
This alarming trend has serious implications, as obesity in childhood can lead to a higher risk of developing serious conditions like high blood pressure, type 2 diabetes and even heart disease later in life
Most patients experience noticeable appetite reduction within 7 to 14 days of their first injection
Strong patient adherence to GLP-1 treatment regimens significantly enhances diabetes management by improving glycemic control, reducing HbA1c levels, and minimizing cardiovascular complications
PMID: 164 FontanaLPartridgeL
